Table S1.
Variables | Cases (n=256) |
Controls (n=531) |
P-valuea | ||
---|---|---|---|---|---|
n | % | n | % | ||
Age range, months | 0–156 | 0.07–156 | 0.239 | ||
≤18 | 101 | 39.45 | 233 | 43.88 | |
>18 | 155 | 60.55 | 298 | 56.12 | |
Mean ± SD | 30.87± | 26.45 | 29.73± | 24.86 | |
Gender | |||||
Female | 103 | 40.23 | 233 | 43.88 | 0.333 |
Male | 153 | 59.77 | 298 | 56.12 | |
Clinical stages | |||||
I | 54 | 21.09 | |||
II | 65 | 25.39 | |||
III | 44 | 17.19 | |||
IV | 77 | 30.08 | |||
4s | 9 | 3.52 | |||
NA | 7 | 2.73 | |||
Sites of origin | |||||
Adrenal gland | 46 | 17.97 | |||
Retroperitoneal region | 87 | 33.98 | |||
Mediastinum | 90 | 35.16 | |||
Other regions | 25 | 9.77 | |||
NA | 8 | 3.13 |
Note:
Two-sided χ2 test for distributions between neuroblastoma cases and controls.
Abbreviation: NA, not available.